Antiabsence drugs and inhibitory pathways

Area of Science:

• Neuroscience
• Pharmacology

Background:

• Inhibitory pathways originating from the coronal gyrus and periventricular gray matter modulate spinal trigeminal neuron activity.
• Several antiepileptic drugs are known to affect neuronal inhibition.

Purpose of the Study:

• To investigate the effects of specific anti-absence drugs on corticofugal and subcortical inhibitory pathways.
• To determine if the ability to depress inhibitory pathways is a key characteristic of anti-absence medications.

Main Methods:

• Electrophysiological recordings of spinal trigeminal neurons.
• Administration of conditioning stimuli to the coronal gyrus and periventricular gray matter.
• Pharmacological manipulation using valproate, ethosuximide, trimethadione, and imipramine.

Main Results:

• Valproate, ethosuximide, trimethadione, and imipramine decreased corticofugal inhibition of the spinal trigeminal nucleus.
• Valproate and ethosuximide reduced periventricular inhibition of the spinal trigeminal nucleus.
• These findings indicate that anti-absence drugs depress both cortical and subcortical inhibitory pathways.

Conclusions:

• The capacity of drugs to depress inhibitory pathways is a significant feature of anti-absence medications.
• Valproate and ethosuximide may exert their anticonvulsant effects by inhibiting the spread of seizure activity through subcortical networks.